Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: Citius | Vintage Vibes

Long jumper Jeswin Aldrin strikes gold in Switzerland

Jeswin Aldrin, world leader in long jump, won gold at Citius athletics meeting in Bern, Switzerland on Friday with 8.22m jump. He had struggled in recent meets due to COVID, but this jump shows he is ready for World Championships in Budapest this month.

The Hindu · Aug 5, 2023

Citius Pharma To Spinoff Late-Stage Oncology Asset Into New Publicly Traded Firm

Citius Pharmaceuticals Inc (NASDAQ:CTXR) plans to form a new company (NewCo) focused on developing and commercializing I/ONTAK. A Phase 3 trial was completed in December 2021, and a biologics license application (BLA) is being planned for submission in the second half of 2022. The Company's other pipeline assets, including Mino-Lok, would remain at…

Benzinga · May 25, 2022

First Patient Dosed in Citius Pharma's Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) announced enrolment of first patient in the Phase 2b clinical study of Halo-Lido for the treatment of hemorrhoids.

Benzinga · Apr 26, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Citius Pharma Reveals Topline Immunotherapy Data From Late-Stage Lymphoma Trial

Citius Pharmaceuticals Inc (NASDAQ:CTXR) reported topline results from the Phase 3 trial of I/ONTAK (E7777) for persistent or recurrent cutaneous T-cell lymphoma (CTCL). I/ONTAK (E7777) is an engineered IL-2-diphtheria toxin fusion protein. No new safety signals were identified. Citius anticipates filing a marketing application with the FDA in 2H of 2022. The Independent…

Benzinga · Apr 6, 2022

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga · Apr 6, 2022

FDA Signs Off Citius Pharma's Phase 2 Trial With Halo-Lido In Hemorrhoids

The

Benzinga · Feb 15, 2022

Coverage From

People

Jeswin Aldrin

57 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.